Neutralizing Antibody Response to
COVID-19
SARS-CoV-2
antigenic imprinting
coronavirus
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
24 06 2022
24 06 2022
Historique:
received:
26
05
2022
revised:
20
06
2022
accepted:
22
06
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
29
7
2022
Statut:
epublish
Résumé
Antigenic imprinting, which describes the bias of the antibody response due to previous immune history, can influence vaccine effectiveness. While this phenomenon has been reported for viruses such as influenza, there is little understanding of how prior immune history affects the antibody response to SARS-CoV-2. This study provides evidence for antigenic imprinting through immunization with two
Identifiants
pubmed: 35891363
pii: v14071382
doi: 10.3390/v14071382
pmc: PMC9318566
pii:
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
Spike Glycoprotein, Coronavirus
0
spike protein, SARS-CoV-2
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Science. 2020 Aug 28;369(6507):1119-1123
pubmed: 32661058
JAMA Netw Open. 2018 Oct 5;1(6):e183742
pubmed: 30646262
J Infect Dis. 2017 Jun 15;215(12):1782-1788
pubmed: 28398521
Cell Rep. 2021 Dec 28;37(13):110169
pubmed: 34932974
Cell Rep. 2020 Jun 2;31(9):107725
pubmed: 33500101
Curr Opin Immunol. 2018 Aug;53:187-195
pubmed: 29890370
Science. 2011 Aug 12;333(6044):843-50
pubmed: 21737702
Science. 2020 May 8;368(6491):630-633
pubmed: 32245784
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7852-7
pubmed: 27354515
Cell Host Microbe. 2019 Jun 12;25(6):836-844.e5
pubmed: 31151913
Trends Immunol. 2018 Jan;39(1):70-79
pubmed: 28867526
JAMA. 2021 Apr 6;325(13):1318-1320
pubmed: 33635317
Emerg Microbes Infect. 2019;8(1):749-759
pubmed: 31130109
Lancet. 2003 Apr 19;361(9366):1319-25
pubmed: 12711465
J Exp Med. 2021 Dec 6;218(12):
pubmed: 34623376
Vaccines (Basel). 2018 May 21;6(2):
pubmed: 29883414
Cell Host Microbe. 2022 Jan 12;30(1):83-96.e4
pubmed: 34965382
Nat Commun. 2021 May 11;12(1):2670
pubmed: 33976165
Nat Biotechnol. 2020 Sep;38(9):1073-1078
pubmed: 32704169
J Gen Virol. 2020 Aug;101(8):791-797
pubmed: 32430094
Nat Commun. 2021 Jun 18;12(1):3781
pubmed: 34145263
Front Pharmacol. 2020 Jun 19;11:937
pubmed: 32636754
N Engl J Med. 2022 Jan 27;386(4):297-299
pubmed: 34910863
N Engl J Med. 2021 Oct 7;385(15):1401-1406
pubmed: 34407341
PLoS Pathog. 2015 Mar 05;11(3):e1004615
pubmed: 25742615
Nat Commun. 2019 Feb 26;10(1):938
pubmed: 30808875
Nat Med. 2015 Dec;21(12):1508-13
pubmed: 26552008
Nat Commun. 2020 Sep 11;11(1):4566
pubmed: 32917903
Front Immunol. 2021 Dec 02;12:795741
pubmed: 34925381
Cell. 2021 Apr 1;184(7):1858-1864.e10
pubmed: 33631096
Nat Med. 2003 Jul;9(7):921-7
pubmed: 12808447
Nature. 1998 Jul 30;394(6692):482-5
pubmed: 9697771
Science. 2016 Nov 11;354(6313):722-726
pubmed: 27846599
mBio. 2016 Jul 19;7(4):
pubmed: 27435464
J Exp Med. 2013 Jul 29;210(8):1493-500
pubmed: 23857983